Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Westlab Pharmacy, Inc. dba Westlab Pharmacy
483
•Westlab Pharmacy, Inc. dba Westlab Pharmacy•October 5, 2021

FDA 483 - Westlab Pharmacy, Inc. dba Westlab Pharmacy - October 05, 2021

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Westlab Pharmacy, Inc. dba Westlab Pharmacy
Record Details

This FDA Form 483 was issued to Westlab Pharmacy Inc. dba Westlab Pharmacy, a producer of sterile and non-sterile drug products, located at 4410 W. Newberry Rd., Gainesville, FL, following an inspection from September 27, 2021, to October 5, 2021. The report details eight observations indicating objectionable conditions and practices.

Key violations include: 1. **Vermin in Production Area:** A large dead insect (wasp) was found in the ceiling light fixture directly above the ISO-5 laminar airflow hood in the ISO-5 Cleanroom, and similar insects were in ceiling light fixtures in the ISO-8 Anteroom. 2. **Non-Microbial Contamination:** Brown stains were observed on the HEPA filter within the ISO-5 laminar airflow hood. A non-sterile suite's equipment had a taped opening that could not be cleaned. Dust accumulated on a fire sprinkler in the non-sterile suite. 3. **Inadequate Environmental Monitoring:** No environmental monitoring (viable/non-viable, surface, personnel) was conducted during or immediately after sterile compounding. 4. **Deficient Media Fills:** Media fills did not simulate worst-case aseptic production, specifically failing to incorporate open sterile dropper containers used for ophthalmic products, instead simulating a closed system. 5. **Aseptic Technique Violations:** A

Company
Westlab Pharmacy, Inc. dba Westlab Pharmacy
Inspection Date
October 5, 2021
Product Type
Drugs
Office
Florida District Office
Person
  • Jessica P. Mcalister (Pharmacy Compounding National Expert at FDA)
Open in Dashboard

ID · b3d4a7b1-1326-4ca9-a8b9-eb7cf3d8bcc6

Violation Codes3
21 CFR 21021 CFR 21121 CFR 331(c)

Full citation text and observation details available on the Dashboard.

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.